Microsaic Systems

NEW YORK (GenomeWeb) – Microsaic Systems and Plexus today announced an agreement for the commercial manufacturing of Microsaic's 4000MiD miniature mass spectrometry system.

NEW YORK (GenomeWeb News) – Miniature mass spectrometry firm Microsaic Systems today reported that revenues for the first half of the year doubled year over year.

With $7 million in new funding, instrument firm 908 Devices is preparing to launch sales of its first miniature mass spec platform in early 2014.

NEW YORK (GenomeWeb News) – UK miniaturized mass spectrometry platform development company Microsaic Systems today announced that revenues more than doubled year over year during the first half of 2012.
The company also announced the appointment of Colin Jump as its new CEO.

NEW YORK (GenomeWeb News) – UK miniature mass spectrometry firm Microsaic Systems today announced a conditional placing of about 3.9 million shares to raise £1.6 million ($2.5 million).

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories disclosed in its 10-Q filed this week that during the first quarter it acquired certain assets from a current raw material supplier for around $12.5 million.

NEW YORK (GenomeWeb News) – Miniaturized mass spectrometry firm Microsaic Systems today announced preliminary results of £267,999 ($432,463) in revenues and a £1.9 million loss for full-year 2011.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Miniaturized mass spectrometry firm Microsaic Systems today announced that its revenues for the first half of 2011 fell 35 percent year over year, while losses increased 30 percent.

The UK firm which went public last month has developed an instrument about the size of a PC targeting laboratories, both small and large, that may not have the space for a conventional platform.

The company said it is the first and only firm to have successfully miniaturized mass specs, using its patented chip-based technology.

NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.

Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.

A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.

In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.